A common signaling pathway is activated in erythroid cells expressing high levels of fetal hemoglobin: a potential role for cAMP-elevating agents in β-globin disorders
Author(s): Ikuta T | Kuroyanagi Y | Odo N | Liu S
Volume: 2013
Issue: default
Year: 2013
Author(s): Ikuta T | Kuroyanagi Y | Odo N | Liu S Volume: 2013 Issue: default Year: 2013
Contribution of blood platelets to vascular pathology in Alzheimer's disease
Author(s): Zhang W | Huang W | Jing F
Volume: 2013
Issue: default
Year: 2013
Author(s): Zhang W | Huang W | Jing F Volume: 2013 Issue: default Year: 2013
Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a network meta-analysis
Author(s): Kinnaird T | Medic G | Casella G | Schiele F | Kaul U | Radke PW | Eijgelshoven I | Bergman G | Chew DP
Volume: 2013
Issue: default
Year: 2013
Author(s): Kinnaird T | Medic G | Casella G | Schiele F | Kaul U | Radke PW | Eijgelshoven I | Bergman G | Chew DP Volume: 2013 Issue: default Year: 2013
Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia
Author(s): Havelange V | Demoulin JB
Volume: 2013
Issue: default
Year: 2013
Author(s): Havelange V | Demoulin JB Volume: 2013 Issue: default Year: 2013
Deferasirox: appraisal of safety and efficacy in long-term therapy
Author(s): Chaudhary P | Pullarkat V
Volume: 2013
Issue: default
Year: 2013
Author(s): Chaudhary P | Pullarkat V Volume: 2013 Issue: default Year: 2013
Current strategies to minimize the bleeding risk of warfarin
Author(s): Snipelisky D | Kusumoto F
Volume: 2013
Issue: default
Year: 2013
Author(s): Snipelisky D | Kusumoto F Volume: 2013 Issue: default Year: 2013
New developments in the management of congenital Factor XIII deficiency [Corrigendum]
Author(s): Fadoo Z | Merchant Q | Rehman KA
Volume: 2013
Issue: default
Year: 2013
Author(s): Fadoo Z | Merchant Q | Rehman KA Volume: 2013 Issue: default Year: 2013
The protective effects of lafutidine for bortezomib induced peripheral neuropathy
Author(s): Tsukaguchi M | Shibano M | Matsuura A | Mukai S
Volume: 2013
Issue: default
Year: 2013
Author(s): Tsukaguchi M | Shibano M | Matsuura A | Mukai S Volume: 2013 Issue: default Year: 2013
Iron stores in regular blood donors in Lagos, Nigeria
Author(s): Adediran A | Uche EI | Adeyemo TA | Damulak OD | Akinbami AA | Akanmu AS
Volume: 2013
Issue: default
Year: 2013
Author(s): Adediran A | Uche EI | Adeyemo TA | Damulak OD | Akinbami AA | Akanmu AS Volume: 2013 Issue: default Year: 2013
New developments in the management of congenital Factor XIII deficiency
Author(s): Fadoo Z | Merchant Q | Rehman KA
Volume: 2013
Issue: default
Year: 2013
Author(s): Fadoo Z | Merchant Q | Rehman KA Volume: 2013 Issue: default Year: 2013
Serum ferritin levels in adults with sickle cell disease in Lagos, Nigeria
Author(s): Akinbami AA | Dosunmu AO | Adediran AA | Oshinaike OO | Osunkalu VO | Ajibola SO | Arogundade OM
Volume: 2013
Issue: default
Year: 2013
Author(s): Akinbami AA | Dosunmu AO | Adediran AA | Oshinaike OO | Osunkalu VO | Ajibola SO | Arogundade OM Volume: 2013 Issue: default Year: 2013
Treatment of patients with von Willebrand disease [Erratum]
Author(s): Tuohy E | Litt E | Alikhan R
Volume: 2013
Issue: default
Year: 2013
Author(s): Tuohy E | Litt E | Alikhan R Volume: 2013 Issue: default Year: 2013
Barriers and perceived limitations to early treatment of hemophilia
Author(s): Saxena K
Volume: 2013
Issue: default
Year: 2013
Author(s): Saxena K Volume: 2013 Issue: default Year: 2013
Lipid profile of regular blood donors
Author(s): Uche EI | Adediran A | Damulak OD | Adeyemo TA | Akinbami AA | Akanmu AS
Volume: 2013
Issue: default
Year: 2013
Author(s): Uche EI | Adediran A | Damulak OD | Adeyemo TA | Akinbami AA | Akanmu AS Volume: 2013 Issue: default Year: 2013
Severe hypernatremia and hyperchloremia in an elderly patient with IgG-kappa-type multiple myeloma
Author(s): Imashuku S | Kudo N | Kubo K
Volume: 2013
Issue: default
Year: 2013
Author(s): Imashuku S | Kudo N | Kubo K Volume: 2013 Issue: default Year: 2013
Beta-amyloidolysis and glutathione in Alzheimer's disease
Author(s): Lasierra-Cirujeda J | Coronel P | Aza MJ | Gimeno M
Volume: 2013
Issue: default
Year: 2013
Author(s): Lasierra-Cirujeda J | Coronel P | Aza MJ | Gimeno M Volume: 2013 Issue: default Year: 2013
Public banking of umbilical cord blood or storage in a private bank: testing social and ethical policy in northeastern Italy
Author(s): Parco S | Vascotto F | Visconti P
Volume: 2013
Issue: default
Year: 2013
Author(s): Parco S | Vascotto F | Visconti P Volume: 2013 Issue: default Year: 2013
Biomarkers for the differentiation of anemia and their clinical usefulness
Author(s): Northrop-Clewes CA | Thurnham DI
Volume: 2013
Issue: default
Year: 2013
Author(s): Northrop-Clewes CA | Thurnham DI Volume: 2013 Issue: default Year: 2013
Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia
Author(s): Widjajanto PH | Sumadiono S | Cloos J | Purwanto I | Sutaryo S | Veerman AJP
Volume: 2013
Issue: default
Year: 2013
Author(s): Widjajanto PH | Sumadiono S | Cloos J | Purwanto I | Sutaryo S | Veerman AJP Volume: 2013 Issue: default Year: 2013
Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation
Author(s): Imashuku S | Kudo N | Kubo K | Saigo K | Okuno N | Tohyama K
Volume: 2012
Issue: default
Year: 2012
Author(s): Imashuku S | Kudo N | Kubo K | Saigo K | Okuno N | Tohyama K Volume: 2012 Issue: default Year: 2012
First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation
Author(s): Piccaluga PP | Paolini S | Bertuzzi C | De Leo A | Rosti G
Volume: 2012
Issue: default
Year: 2012
Author(s): Piccaluga PP | Paolini S | Bertuzzi C | De Leo A | Rosti G Volume: 2012 Issue: default Year: 2012
Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia
Author(s): Baran Y | Saydam G
Volume: 2012
Issue: default
Year: 2012
Author(s): Baran Y | Saydam G Volume: 2012 Issue: default Year: 2012
Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)
Author(s): Young G | Solem CT | Hoffman K | Kabawat J | Pickard AS | Gut RZ | Cooper DL
Volume: 2012
Issue: default
Year: 2012
Author(s): Young G | Solem CT | Hoffman K | Kabawat J | Pickard AS | Gut RZ | Cooper DL Volume: 2012 Issue: default Year: 2012
Treating thalassemia major-related iron overload: the role of deferiprone
Author(s): Berdoukas V | Farmaki K | Carson S | Wood J | Coates T
Volume: 2012
Issue: default
Year: 2012
Author(s): Berdoukas V | Farmaki K | Carson S | Wood J | Coates T Volume: 2012 Issue: default Year: 2012
Determination of reference ranges for full blood count parameters in neonatal cord plasma in Hilla, Babil, Iraq
Author(s): Al-Marzoki JM | Al-Maaroof ZW | Kadhum AH
Volume: 2012
Issue: default
Year: 2012
Author(s): Al-Marzoki JM | Al-Maaroof ZW | Kadhum AH Volume: 2012 Issue: default Year: 2012
Barriers in transition from pediatrics to adult medicine in sickle cell anemia
Author(s): Lebensburger JD | Bemrich-Stolz CJ | Howard TH
Volume: 2012
Issue: default
Year: 2012
Author(s): Lebensburger JD | Bemrich-Stolz CJ | Howard TH Volume: 2012 Issue: default Year: 2012
Ethical and legal considerations regarding the ownership and commercial use of human biological materials and their derivatives
Author(s): Petrini C
Volume: 2012
Issue: default
Year: 2012
Author(s): Petrini C Volume: 2012 Issue: default Year: 2012
Optimal management of pernicious anemia
Author(s): Andres E | Serraj K
Volume: 2012
Issue: default
Year: 2012
Author(s): Andres E | Serraj K Volume: 2012 Issue: default Year: 2012
Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?
Author(s): Barton Pai A | Garba AO
Volume: 2012
Issue: default
Year: 2012
Author(s): Barton Pai A | Garba AO Volume: 2012 Issue: default Year: 2012
Newer agents in antiplatelet therapy: a review
Author(s): Yeung J | Holinstat M
Volume: 2012
Issue: default
Year: 2012
Author(s): Yeung J | Holinstat M Volume: 2012 Issue: default Year: 2012
Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
Author(s): Saba HI | Tran DQ Jr
Volume: 2012
Issue: default
Year: 2012
Author(s): Saba HI | Tran DQ Jr Volume: 2012 Issue: default Year: 2012
7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal
Author(s): Kapoor S
Volume: 2012
Issue: default
Year: 2012
Author(s): Kapoor S Volume: 2012 Issue: default Year: 2012
Reducing the risk of hepatitis B virus transfusion-transmitted infection
Author(s): Niederhauser C
Volume: 2011
Issue: default
Year: 2011
Author(s): Niederhauser C Volume: 2011 Issue: default Year: 2011
Treatment of anemia in chronic kidney disease: known, unknown, and both
Author(s): Foley RN
Volume: 2011
Issue: default
Year: 2011
Author(s): Foley RN Volume: 2011 Issue: default Year: 2011
Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly
Author(s): Lerman Y | Werber MM | Fine I | Kemelman P
Volume: 2011
Issue: default
Year: 2011
Author(s): Lerman Y | Werber MM | Fine I | Kemelman P Volume: 2011 Issue: default Year: 2011
An update on the management of peripheral T-cell lymphoma and emerging treatment options
Author(s): Phillips AA | Owens C | Lee S | Bhagat G
Volume: 2011
Issue: default
Year: 2011
Author(s): Phillips AA | Owens C | Lee S | Bhagat G Volume: 2011 Issue: default Year: 2011
Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery
Author(s): Barua A | Rao VP | Ramesh BC | Barua B | El-Shafei H
Volume: 2011
Issue: default
Year: 2011
Author(s): Barua A | Rao VP | Ramesh BC | Barua B | El-Shafei H Volume: 2011 Issue: default Year: 2011
Management of transfusional iron overload – differential properties and efficacy of iron chelating agents
Author(s): Kwiatkowski JL
Volume: 2011
Issue: default
Year: 2011
Author(s): Kwiatkowski JL Volume: 2011 Issue: default Year: 2011
Emerging treatments for essential thrombocythemia
Author(s): Okoli S | Harrison C
Volume: 2011
Issue: default
Year: 2011
Author(s): Okoli S | Harrison C Volume: 2011 Issue: default Year: 2011
The wandering spleen: an unusual case of thrombocytopenia
Author(s): Mirkes C | Nguyen G | Cable C
Volume: 2011
Issue: default
Year: 2011
Author(s): Mirkes C | Nguyen G | Cable C Volume: 2011 Issue: default Year: 2011
Lupus anticoagulant (LA) in pregnant women with history of recurrent fetal loss
Author(s): Olaniyi JA | Olomu SA | Finomo SA
Volume: 2011
Issue: default
Year: 2011
Author(s): Olaniyi JA | Olomu SA | Finomo SA Volume: 2011 Issue: default Year: 2011
Subclinical leukopenia in a cross section of Nigerian blood donors
Author(s): Jeremiah ZA | Umoh RE | Adias TC
Volume: 2011
Issue: default
Year: 2011
Author(s): Jeremiah ZA | Umoh RE | Adias TC Volume: 2011 Issue: default Year: 2011
Deep vein thrombosis: a clinical review
Author(s): Kesieme EB | Kesieme CN | Jebbin N | Irekpita E | Dongo A
Volume: 2011
Issue: default
Year: 2011
Author(s): Kesieme EB | Kesieme CN | Jebbin N | Irekpita E | Dongo A Volume: 2011 Issue: default Year: 2011
Romidepsin in the treatment of cutaneous T-cell lymphoma
Author(s): Jain S | Zain J
Volume: 2011
Issue: default
Year: 2011
Author(s): Jain S | Zain J Volume: 2011 Issue: default Year: 2011
TachoSil use in abdominal surgery: a review
Author(s): Adriana Toro | Maurizio Mannino | Giulio Reale | et al
Volume: 2011
Issue: default
Year: 2011
Author(s): Adriana Toro | Maurizio Mannino | Giulio Reale | et al Volume: 2011 Issue: default Year: 2011
The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood
Author(s): Erhabor Osaro | Adias Teddy Charles
Volume: 2011
Issue: default
Year: 2011
Author(s): Erhabor Osaro | Adias Teddy Charles Volume: 2011 Issue: default Year: 2011
Emerging role of rasburicase in the management of increased plasma uric acid levels in patients with hematologic malignancies
Author(s): LeAnne D Kennedy | Susannah Koontz | Kamakshi Rao
Volume: 2011
Issue: default
Year: 2011
Author(s): LeAnne D Kennedy | Susannah Koontz | Kamakshi Rao Volume: 2011 Issue: default Year: 2011
Solitary plasmacytoma of the jaw
Author(s): Serena Marotta | Pierpaolo Di Micco
Volume: 2010
Issue: default
Year: 2010
Author(s): Serena Marotta | Pierpaolo Di Micco Volume: 2010 Issue: default Year: 2010
Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors
Author(s): Ampaiwan Chuansumrit | Pantep Angchaisuksiri | Nongnuch Sirachainan
Volume: 2010
Issue: default
Year: 2010
Author(s): Ampaiwan Chuansumrit | Pantep Angchaisuksiri | Nongnuch Sirachainan Volume: 2010 Issue: default Year: 2010
Role of ofatumumab in treatment of chronic lymphocytic leukemia
Author(s): Veliz M | Pinilla-Ibarz J
Volume: 2011
Issue: default
Year: 2011
Author(s): Veliz M | Pinilla-Ibarz J Volume: 2011 Issue: default Year: 2011
Treatment of patients with von Willebrand disease
Author(s): Tuohy E | Litt E | Alikhan R
Volume: 2011
Issue: default
Year: 2011
Author(s): Tuohy E | Litt E | Alikhan R Volume: 2011 Issue: default Year: 2011
A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonists
Author(s): Meaghan Khan | Joseph Mikhael
Volume: 2010
Issue: default
Year: 2010
Author(s): Meaghan Khan | Joseph Mikhael Volume: 2010 Issue: default Year: 2010
Homeostatic and pathogenic extramedullary hematopoiesis
Author(s): Chang H Kim
Volume: 2010
Issue: default
Year: 2010
Author(s): Chang H Kim Volume: 2010 Issue: default Year: 2010
Venous thromboembolism and pregnancy
Author(s): Maristella D’Uva | Pierpaolo Di Micco | Ida Strina | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Maristella D’Uva | Pierpaolo Di Micco | Ida Strina | et al Volume: 2010 Issue: default Year: 2010
The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies
Author(s): Jorge Castillo | Kimberly Perez
Volume: 2010
Issue: default
Year: 2010
Author(s): Jorge Castillo | Kimberly Perez Volume: 2010 Issue: default Year: 2010
